RHHBY : Summary for ROCHE HLDG LTD SPONS - Yahoo Finance

U.S. Markets close in 4 hrs 30 mins

Roche Holding AG (RHHBY)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
30.30-0.31 (-1.00%)
As of 11:14AM EST. Market open.
People also watch
NVSSNYNSRGYAZNBAYRY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close30.60
Open30.22
Bid0.00 x
Ask0.00 x
Day's Range30.19 - 30.32
52 Week Range25.25 - 33.77
Volume192,013
Avg. Volume1,412,829
Market Cap205.44B
Beta0.64
PE Ratio (TTM)21.71
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.02 (3.33%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire1 hour ago

    New frontiers in cancer research and treatment to be explored by global experts at Tucson Symposium

    TUCSON, Ariz., Feb. 27, 2017 /PRNewswire/ -- More than 500 pathologists, oncologists, scientific researchers and healthcare leaders will converge in Tucson for the 13th annual Tucson Symposium, February 28 to March 1. The two-day conference, which is sponsored by Ventana Medical Systems, Inc., a member of the Roche Group, draws top scientific collaborators from around the globe to hear from leading experts about the latest hypotheses, breakthroughs and innovations in cancer research and treatments. Topics will focus on developments in immunotherapy, genomics, technology, tumor heterogeneity and cancer evolution and personalized healthcare.

  • Investopedia3 days ago

    Novartis Lung Cancer Drug Combo Gets CHMP Nod

    Novartis has secured a positive opinion from European CHMP for its lung cancer drug combo.

  • Investopedia3 days ago

    Novartis Cancer Drug Zykadia Gets Priority Review

    Lung cancer drug Zykadia got priority review status and breakthrough designation from the FDA.